Table 3.
Clinical and Demographic Data of 992 Tests in 913 Patients Who Had the SAMBA II SARS-CoV-2 Test in the Post-implementation Period
| (N) Individual Patients = 913/Tests = 992 | |
|---|---|
| Male gender (%) | n = 857/913 |
| 389 (44.6) | |
| Median age, y (IQR) | n = 909/913 |
| 63 (37–79) | |
| Duration of illness, days (IQR) | 2 (1–7) |
| SAMBA II SARS-CoV2 result (%) | |
| Positive | 42 (4.2) |
| Negative | 950 (95.8) |
| Triage at initial assessment (%) | n = 966/992 |
| Non-COVID-19 (green) | 478 (49.5) |
| Possible COVID-19 (amber) | 387 (40.0) |
| Likely COVID-19 (red) | 101 (10.5) |
| Inpatient transfer (%) | n = 976/992 |
| Yes | 20 (2.0) |
| No | 956 (98.0) |
| Triage following SAMBA II SARS-CoV-2 result (%) | n = 756/992 |
| Non-COVID-19 (green) | 600 (79.4) |
| Possible COVID-19 (amber) | 88 (11.6) |
| Likely COVID-19 (red) | 68 (9.0) |
| Reason for SARS-CoV-2 test | n = 970/992 |
| Admission triage and placement | 580 (59.8) |
| In-hospital triage and placement | 94 (9.7) |
| Discharge to nursing home/carers | 97 (10.0) |
| Pre-operative | 110 (11.3) |
| Facilitate other investigations | 12 (1.2) |
| Asymptomatic screening | 37 (3.8) |
| Other | 40 (4.1) |
Note that some individuals had multiple admissions each with associated POC tests. COVID-19, coronavirus disease 2019; IQR, interquartile range; POC, point of care; SAMBA, simple amplification-based assay; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2.